Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Buckhenryon Dec 20, 2022 2:14pm
79 Views
Post# 35182747

RE:RE:RE:Newbies...ignore the vapid FUD attempts...

RE:RE:RE:Newbies...ignore the vapid FUD attempts...
 
 
Stockhouse Logo
Join Now
Sign In
Search Companies, etc
 
 
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Oncolytics Biotech Inc. ONCY
 
Primary Symbol: T.ONC Alternate Symbol(s):  ONCWF
Healthcare Biotechnology
Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq.
$1.90090.0509 | 2.75%Bid: 1.90 x 200Ask: 1.91 x 300Volume: 156,917
USDNASDAQ CAPITAL MARKETDELAYED PRICEDECEMBER 20, 2022 1:55 PMEST
Oncolytics Biotech Inc. > RE:RE:keep pumping this dog sh**T
New Post
« Older Post
View Thread
Newer Post »
View All Posts
 
 0
+  Favorites
 
Buckhenry (22)
User Actions  
December 19, 2022 - 09:40 PM
62 Reads
Post# 35181241
RE:RE:keep pumping this dog sh**T
u folks need to learn to live in a society where you don't get ur way and not everyone agrees with your narrative. u folks fundamentally want a dictatorship where you can get rid of anyone who don't believe ur ideology. ur answer is too always tell me to leave....
<< Previous
Bullboard Posts
Next >>